What's Behind The 15% Fall For Elevance Health Stock?
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus ...
Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
Elevance Health's dependence on government plans is considerable, but even with very conservative growth expectations, ELV ...
Elevance Health Latest Insurer Battered By Higher Medical Costs
Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits ...
Elevance Health: Strong Financial Performance and Strategic Value Create Attractive Investment Opportunity
In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a ...
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Elevance Health faces profitability issues, impacting its stock price. See more about ELV stock's cautious hold rating and ...
Elevance Health price target lowered to $549 from $665 at Bernstein
Bernstein lowered the firm’s price target on Elevance Health (ELV) to $549 from $665 and keeps an Outperform rating on the shares. The ...
S&P 500 Gains and Losses Today: Health Insurers Slide as Elevance Cites Medicaid Declines
Key Takeaways The S&P 500 was essentially flat on Thursday, Oct. 17, closing less than 0.1% lower despite strong retail sales ...
Modern Healthcare2d
Elevance launches bond sale in wake of stock slump
Elevance Health Inc. is seeking to sell investment-grade bonds as the big US insurer’s shares have fallen the most since 2020 ...
Elevance Health slashes profit forecast on persistently high medical costs
Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, ...
Is Elevance Health, Inc. (NYSE:ELV) the Most Undervalued Value Stock to Buy According to Analysts?
We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...
Elevance Health (NYSE:ELV) Price Target Lowered to $484.00 at TD Cowen
Elevance Health (NYSE:ELV – Get Free Report) had its price objective dropped by stock analysts at TD Cowen from $589.00 to $484.00 in a report released on Monday, Benzinga reports. The brokerage ...
Elevance Health Stock Plunges on Profit Hit From Fall in Medicaid Memberships
Elevance Health shares plunged Thursday after the insurer reported lower-than-expected earnings and cut its outlook as ...